Literature DB >> 6934522

Human platelet basic protein associated with antiheparin and mitogenic activities: purification and partial characterization.

D Paul, S Niewiarowski, K G Varma, B Rucinski, S Rucker, E Lange.   

Abstract

Platelet basic protein (PBP) (isoelectric point, 10.0-10.5; apparent Mr, 11,000-15,000) has been purified to homogeneity from material secreted by fresh human platelets after stimulation by thrombin. The purification, using preparative isoelectric focusing and chromatography on heparin-Sepharose, yielded two additional peptides with antiheparin activity that were immunologically identical with PBP: low-affinity platelet factor 4 and beta-thromboglubulin. The purity of the peptides was confirmed by immuoelectrophoresis and by NH2-terminal amino acid analysis. Dansyl chloride-treated PBP yielded a single dansylated amino acid residue (glycine). By using a specific radioimmunoassay it was shown that 10(9) human platelets contain 2-3 microgram of PBP which can be released in response to specific stimulation. PBP is associated with mitogenic activity as assayed in Swiss 3T3 mouse cells cultured in low-serum (0.4-1.5%) medium at levels of about 1 ng/ml and saturating at 10-40 ng/ml. The biological activity of different PBP preparations was variable, presumably due to inhibition by the varying amounts of ampholytes that interfered with the mitogenic activity of the peptide. Mitogenic activity was eluted from NaDodSO4/polyacrylamide gels and shown to comigrate with immunoreactive material and with conventional marker proteins of 14,000-17,000 daltons or with histones of 11,000-15,000 daltons. Evidence is presented that PBP is different from cationic platelet-derived growth factor which has an apparent Mr of 30,000.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6934522      PMCID: PMC350182          DOI: 10.1073/pnas.77.10.5914

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Purification of a fibroblast growth factor from bovine pituitary.

Authors:  D Gospodarowicz
Journal:  J Biol Chem       Date:  1975-04-10       Impact factor: 5.157

2.  Partial purification and characterization of platelet factors stimulating the multiplication of normal human glial cells.

Authors:  C H Heldin; A Wasteson; B Westermark
Journal:  Exp Cell Res       Date:  1977-10-15       Impact factor: 3.905

3.  Preparation of suspensions of washed platelets from humans.

Authors:  J F Mustard; D W Perry; N G Ardlie; M A Packham
Journal:  Br J Haematol       Date:  1972-02       Impact factor: 6.998

4.  Platelets as a source of fibroblast growth-promoting activity.

Authors:  N Kohler; A Lipton
Journal:  Exp Cell Res       Date:  1974-08       Impact factor: 3.905

5.  Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization.

Authors:  C R Savage; S Cohen
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

6.  The molecular weights of vertebrate histones exploiting a modified sodium dodecyl sulfate electrophoretic method.

Authors:  S Panyim; R Chalkley
Journal:  J Biol Chem       Date:  1971-12-25       Impact factor: 5.157

7.  A method for producing specific antisera with small doses of immunogen.

Authors:  J Vaitukaitis; J B Robbins; E Nieschlag; G T Ross
Journal:  J Clin Endocrinol Metab       Date:  1971-12       Impact factor: 5.958

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro.

Authors:  R Ross; J Glomset; B Kariya; L Harker
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

10.  Human platelet factor 4: Purification and characterization by affinity chromatography. Purification of human platelet factor 4.

Authors:  S P Levine; H Wohl
Journal:  J Biol Chem       Date:  1976-01-25       Impact factor: 5.157

View more
  7 in total

1.  Monocyte-derived CXCL7 peptides in the marrow microenvironment.

Authors:  Manoj M Pillai; Mineo Iwata; Norihiro Awaya; Lynn Graf; Beverly Torok-Storb
Journal:  Blood       Date:  2006-01-03       Impact factor: 22.113

2.  Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures.

Authors:  T Nakamura; H Teramoto; A Ichihara
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

Review 3.  Adhesive receptors expressed by tumor cells and platelets: novel targets for therapeutic anti-metastatic strategies.

Authors:  L Oleksowicz; J P Dutcher
Journal:  Med Oncol       Date:  1995-06       Impact factor: 3.064

4.  Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.

Authors:  D M Tollefsen; C A Pestka
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

5.  Mitogenic factors present in serum but not in plasma.

Authors:  S D Balk; S P Levine; L L Young; M M LaFleur; N M Raymond
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

6.  Immunocytochemical localization of fibrinogen, platelet factor 4, and beta thromboglobulin in thin frozen sections of human blood platelets.

Authors:  H J Sander; J W Slot; B N Bouma; P A Bolhuis; D S Pepper; J J Sixma
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

7.  Synthesis of a novel cytokine and its gene (LD78) expressions in hematopoietic fresh tumor cells and cell lines.

Authors:  Y Yamamura; T Hattori; K Obaru; K Sakai; N Asou; K Takatsuki; Y Ohmoto; H Nomiyama; K Shimada
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.